Therapeutic immune monitoring of CD4(+)CD25(+) T cells in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors

Tyrosine kinase inhibitors (TKIs), including imatinib, dasatinib and nilotinib, are effective forms of therapy for various types of solid cancers and Philadelphia chromosome-positive (Ph(+)) chronic myeloid leukemia. A number of TKIs have been known to have strong effects on T cells, particularly cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Ziyuan, Xu, Na, Zhou, Xuan, Gao, Guanlun, Li, Lin, Huang, Jixian, Li, Yuling, Lu, Qisi, He, Bolin, Pan, Chengyun, Liu, Xiaoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542035/
https://www.ncbi.nlm.nih.gov/pubmed/28808483
http://dx.doi.org/10.3892/ol.2017.6294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542035/
https://www.ncbi.nlm.nih.gov/pubmed/28808483
http://dx.doi.org/10.3892/ol.2017.6294

Ejemplares similares